Skip to main content
All lobbying clients

BRISTOL MYERS SQUIBB COMPANY

Lobbying client · District of Columbia · filed 2025 to 2026

Global biopharmaceutical company.

$20,790,000 Reported spend
81 Filings counted
15 Outside firms hired
23 Bills named

Spend is reported income plus in-house expenses across 81 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 16 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as BRISTOL MYERS SQUIBB, BRISTOL-MYERS SQUIBB, BRISTOL-MYERS SQUIBB COMPANY.

 Who filed for this client 16

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 23
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    12 filings
  • H.R. 1
    One Big Beautiful Bill Act
    8 filings
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    7 filings
  • S. 864
    HELP Copays Act
    7 filings
  • H.R. 7635
    The 340B PATIENTS Act of 2024
    6 filings
  • H.R. 830
    HELP Copays Act
    6 filings
  • H.R. 5509
    Safe Step Act
    4 filings
  • S. 891
    Bipartisan Health Care Act
    4 filings
  • S. 1339
    Pharmacy Benefit Manager Reform Act
    3 filings
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    3 filings
  • H.R. 7391
    Community Health Center Drug Pricing Protection Act
    3 filings
  • H.R. 3285
    Fairness for Patient Medications Act
    2 filings
  • H.R. 3521
    Clinical Trial Modernization Act
    2 filings
  • S. 3019
    No Big Blockbuster Bailouts Act
    2 filings
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
    2 filings
  • H.R. 5378
    Lower Costs, More Transparency Act
    1 filing
  • H.R. 8412
    Clinical Trial Modernization Act
    1 filing
  • S. 127
    Pharmacy Benefit Manager Transparency Act of 2023
    1 filing
  • S. 2973
    Modernizing and Ensuring PBM Accountability Act
    1 filing
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    1 filing
  • H.R. 3283
    FARMER Act
    1 filing
  • H.R. 946
    ORPHAN Cures Act
    1 filing
  • S. 1862
    ORPHAN Cures Act
    1 filing
 Reported by year 2 years
  • 2026 $9,550,000 47 filings
  • 2025 $11,240,000 34 filings
 Issues lobbied 9

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 58
  • SENATE 56
  • Centers For Medicare and Medicaid Services (CMS) 18
  • Food & Drug Administration (FDA) 3
  • White House Office 2
  • Executive Office of the President (EOP) 1
 Recent filings 81 total
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
ALEXANDER J. BECKLES, L.L.C.
3rd Quarter 2026 (July 1 - Sep 30) · $30,000 income · posted Oct 20, 2026
View →
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
MILLER STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
BRISTOL-MYERS SQUIBB COMPANY
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $3,050,000 expenses · posted Oct 20, 2026
View →
Q3 report
THE MCMANUS GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
WILLIAMS AND JENSEN, PLLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
SPLITOAK STRATEGIES LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
AVENUE SOLUTIONS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 19, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 19, 2026
View →
Q3 report
ADVANCED POLICY CONSULTING, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 13, 2026
View →
Registration
ADVANCED POLICY CONSULTING, LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Aug 4, 2026
View →
Q2 report
FEDERAL STREET STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
BRISTOL-MYERS SQUIBB COMPANY
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $3,160,000 expenses · posted Jul 20, 2026
View →
Q2 report
MILLER STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 20, 2026
View →
Q2 report
SPLITOAK STRATEGIES LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 81 filings. Search the explorer for "BRISTOL MYERS SQUIBB COMPANY".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem